dinapsoline dinapsoline dinapsoline is a drug developed for the treatment of parkinson's disease, that acts as a selective full agonist at the dopamine d1 receptor. dinapsolineclinical dataatc codenoneidentifiers iupac name 8,9-dihydroxy-2,3,7,11b-tetrahydro-1h-naphisoquinoline cas number458563-40-1 ypubchem cid9816455chemspider7992205 nuniigz9xc6c5p9comptox dashboard (epa)dtxsid50431229 chemical and physical dataformulac16h15no2molar mass253.301 g·mol−13d model (jsmol)interactive image smiles oc1c3c(ccc1o)4c2c(cccc2c3)cnc4 inchi inchi=1s/c16h15no2/c18-14-5-4-11-12(16(14)19)6-9-2-1-3-10-7-17-8-13(11)15(9)10/h1-5,13,17-19h,6-8h2/t13-/m0/s1 nkey:zqtsngjhmuklom-zdusscgksa-n n ny (what is this?) (verify)